levalbuterol inhalation (Dr. Reddy¿s Laboratories, Inc.)


Welcome to the PulseAid listing for the levalbuterol inhalation drug offered from Dr. Reddy¿s Laboratories, Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr. Reddy¿s Laboratories, Inc.
NON-PROPRIETARY NAME: levalbuterol inhalation 1.25mg/3mL
SUBSTANCE NAME: LEVALBUTEROL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-09-16
END MARKETING DATE: 0000-00-00


levalbuterol inhalation HUMAN PRESCRIPTION DRUG Details:

Item Descriptionlevalbuterol inhalation from Dr. Reddy¿s Laboratories, Inc.
LABELER NAME: Dr. Reddy¿s Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.25(mg/3mL)
START MARKETING DATE: 2014-09-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43598-409_13c2f13e-32da-66f4-294e-a89c3f50a206
PRODUCT NDC: 43598-409
APPLICATION NUMBER: ANDA078171

Other LEVALBUTEROL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dr. Reddy¿s Laboratories, Inc.levalbuterol inhalation